Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti Obesity Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti Obesity Drugsmarket, defines the market attractiveness level of Anti Obesity Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti Obesity Drugs industry, describes the types of Anti Obesity Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti Obesity Drugs market and the development prospects and opportunities of Anti Obesity Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti Obesity Drugs market in Chapter 13.
By Player:
Zafgan
Merck
GlaxoSmithKline
Rhythm Pharmaceuticals
Boehringer Ingelheim
Orexigen Therapeutics
Pfizer
Vivus
Shionogi
Alizyme
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Norgine
Roche
Eisai
By Type:
Oral Medicine
Diet Patch
Other
By End-User:
Men
Women
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti Obesity Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti Obesity Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti Obesity Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti Obesity Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti Obesity Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti Obesity Drugs Consumption (2017-2022)
-
7.2 United States Anti Obesity Drugs Consumption (2017-2022)
-
7.3 Europe Anti Obesity Drugs Consumption (2017-2022)
-
7.4 China Anti Obesity Drugs Consumption (2017-2022)
-
7.5 Japan Anti Obesity Drugs Consumption (2017-2022)
-
7.6 India Anti Obesity Drugs Consumption (2017-2022)
-
7.7 South Korea Anti Obesity Drugs Consumption (2017-2022)
8 Region and Country-wise Anti Obesity Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti Obesity Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti Obesity Drugs Consumption Forecast (2022-2028)
9 Global Anti Obesity Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti Obesity Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Medicine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diet Patch Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti Obesity Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Men Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Women Consumption and Growth Rate (2017-2022)
10 Global Anti Obesity Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti Obesity Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diet Patch Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti Obesity Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Men Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Women Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti Obesity Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti Obesity Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti Obesity Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti Obesity Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti Obesity Drugs Market Competitive Analysis
-
14.1 Zafgan
-
14.1.1 Zafgan Company Details
-
14.1.2 Zafgan Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Zafgan Anti Obesity Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Anti Obesity Drugs Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Anti Obesity Drugs Product and Service
-
14.4 Rhythm Pharmaceuticals
-
14.4.1 Rhythm Pharmaceuticals Company Details
-
14.4.2 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Rhythm Pharmaceuticals Anti Obesity Drugs Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Anti Obesity Drugs Product and Service
-
14.6 Orexigen Therapeutics
-
14.6.1 Orexigen Therapeutics Company Details
-
14.6.2 Orexigen Therapeutics Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Orexigen Therapeutics Anti Obesity Drugs Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Anti Obesity Drugs Product and Service
-
14.8 Vivus
-
14.8.1 Vivus Company Details
-
14.8.2 Vivus Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vivus Anti Obesity Drugs Product and Service
-
14.9 Shionogi
-
14.9.1 Shionogi Company Details
-
14.9.2 Shionogi Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Shionogi Anti Obesity Drugs Product and Service
-
14.10 Alizyme
-
14.10.1 Alizyme Company Details
-
14.10.2 Alizyme Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Alizyme Anti Obesity Drugs Product and Service
-
14.11 Arena Pharmaceuticals
-
14.11.1 Arena Pharmaceuticals Company Details
-
14.11.2 Arena Pharmaceuticals Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Arena Pharmaceuticals Anti Obesity Drugs Product and Service
-
14.12 Novo Nordisk
-
14.12.1 Novo Nordisk Company Details
-
14.12.2 Novo Nordisk Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novo Nordisk Anti Obesity Drugs Product and Service
-
14.13 AstraZeneca
-
14.13.1 AstraZeneca Company Details
-
14.13.2 AstraZeneca Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 AstraZeneca Anti Obesity Drugs Product and Service
-
14.14 Norgine
-
14.14.1 Norgine Company Details
-
14.14.2 Norgine Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Norgine Anti Obesity Drugs Product and Service
-
14.15 Roche
-
14.15.1 Roche Company Details
-
14.15.2 Roche Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Roche Anti Obesity Drugs Product and Service
-
14.16 Eisai
-
14.16.1 Eisai Company Details
-
14.16.2 Eisai Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Eisai Anti Obesity Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti Obesity Drugs
-
Figure Anti Obesity Drugs Picture
-
Table Global Anti Obesity Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Obesity Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Obesity Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti Obesity Drugs Consumption by Country (2017-2022)
-
Figure United States Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti Obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti Obesity Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti Obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Diet Patch Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Men Consumption and Growth Rate (2017-2022)
-
Figure Global Women Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diet Patch Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Men Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Women Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti Obesity Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti Obesity Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Zafgan (Foundation Year, Company Profile and etc.)
-
Table Zafgan Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zafgan Anti Obesity Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti Obesity Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti Obesity Drugs Product and Service
-
Table Rhythm Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rhythm Pharmaceuticals Anti Obesity Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Anti Obesity Drugs Product and Service
-
Table Orexigen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Orexigen Therapeutics Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orexigen Therapeutics Anti Obesity Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti Obesity Drugs Product and Service
-
Table Vivus (Foundation Year, Company Profile and etc.)
-
Table Vivus Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vivus Anti Obesity Drugs Product and Service
-
Table Shionogi (Foundation Year, Company Profile and etc.)
-
Table Shionogi Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shionogi Anti Obesity Drugs Product and Service
-
Table Alizyme (Foundation Year, Company Profile and etc.)
-
Table Alizyme Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alizyme Anti Obesity Drugs Product and Service
-
Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arena Pharmaceuticals Anti Obesity Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Anti Obesity Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti Obesity Drugs Product and Service
-
Table Norgine (Foundation Year, Company Profile and etc.)
-
Table Norgine Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Norgine Anti Obesity Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Anti Obesity Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Anti Obesity Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Anti Obesity Drugs Product and Service
-
